
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
        <meta name="author" content="YW Chen">
      
      
        <link rel="canonical" href="https://didiowen.github.io/notes-not-scandal/archive/2024/page/3/">
      
      
        <link rel="prev" href="../../../../category/writing/">
      
      
        <link rel="next" href="../../../2023/">
      
      
      <link rel="icon" href="../../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.33">
    
    
      
        <title>2024 - Notes Not Scandal</title>
      
    
    
      <link rel="stylesheet" href="../../../../assets/stylesheets/main.3cba04c6.min.css">
      
        
        <link rel="stylesheet" href="../../../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../../../css/timeago.css">
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    
    <script>__md_scope=new URL("../../../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#2024" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../../.." title="Notes Not Scandal" class="md-header__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Notes Not Scandal
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              2024
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="pink" data-md-color-accent="blue"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../../.." title="Notes Not Scandal" class="md-nav__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    Notes Not Scandal
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2" checked>
        
          
          <label class="md-nav__link" for="__nav_2" id="__nav_2_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Archive
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_2_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_2">
            <span class="md-nav__icon md-icon"></span>
            Archive
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
      
    
  
  
    <li class="md-nav__item">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
      <a href="../../" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    2024
  </span>
  

      </a>
      
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../2023/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2023
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Categories
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            Categories
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/abx/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    abx
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/hiv/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    hiv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/medicine/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    medicine
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/reading/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    reading
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/taiwanese/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    taiwanese
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/tb/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    tb
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/travelling/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    travelling
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../category/writing/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    writing
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
  <div class="md-content" data-md-component="content">
    <div class="md-content__inner">
      <header class="md-typeset">
        <h1 id="2024">2024<a class="headerlink" href="#2024" title="Permanent link">&para;</a></h1>
      </header>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-05-22 00:00:00">May 22, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../../../category/medicine/" class="md-meta__link">medicine</a>, 
              <a href="../../../../category/abx/" class="md-meta__link">abx</a></li>
        
        
          
          <li class="md-meta__item">
            
              1 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="linezolid"><a class="toclink" href="../../../../medicine/linezolid/">Linezolid健保給付條件</a></h2>
<p>108/4/1<br />
1. 限下列條件之一使用：<br />
    1. 確定或高度懷疑為MRSA 肺炎（痰液培養出MRSA，伴隨全身發炎反應，且CXR 出現新的浸潤或痰液性狀改變或氧氣需求增加），並符合下列危險因子之一：（105/2/1、108/4/1）<br />
        1. 65歲以上。<br />
        2. BMI≧30。<br />
        3. 急性腎衰竭、腎功能不穩定時。<br />
        4. 過去90天內曾使用glycopeptides 者。（108/4/1）<br />
    2. 因嚴重肺炎致呼吸衰竭或合併嚴重敗血症之患者，同時有其他部位懷疑或證實為MRSA 感染，得以經驗性使用；惟後續呼吸道微生物學檢查結果無MRSA呼吸道感染證據時，應停止使用。（108/4/1）<br />
    3. 證實為MRSA 複雜性皮膚和皮膚構造感染，並符合下列條件之一：（108/4/1）<br />
        1. 有全身性感染徵兆且白血球數異常（&gt;12,000或&lt;4,000 cells/mcL）。<br />
        2. 免疫功能不全。<br />
    4. 證實為VRE（vancomycin-resistant enterococci)感染，且其VRE 菌株對ampicillin 為抗藥者。（108/4/1）<br />
    5. 其他抗藥性革蘭氏陽性球菌感染，因病情需要，經感染症專科醫師會診確認需要使用者。<br />
2. 心內膜炎（endocarditis）病患不建議使用。（108/4/1）<br />
3. 申報費用時需檢附會診紀錄或相關之病歷資料。</p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-04-18 00:00:00">April 18, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../../../category/medicine/" class="md-meta__link">medicine</a></li>
        
        
          
          <li class="md-meta__item">
            
              3 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="daa"><a class="toclink" href="../../../../medicine/daa/">DAA</a></h2>
<h3 id="glecaprevirpibrentasvir-maviret"><a class="toclink" href="../../../../medicine/daa/#glecaprevirpibrentasvir-maviret">Glecaprevir/pibrentasvir (Maviret)</a></h3>
<ul>
<li>3# QD WM，Child-Pugh B/C不可使用，腎功能不佳可使用  </li>
<li>限使用於 HCV RNA 為陽性及無肝功能代償不全之病毒基因型第 1 型、第 2 型、第 3 型、第 4 型、第 5 型或第 6 型 12 歲（含）以上病患  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>未曾接受治療之患者，給付 8 週  </li>
<li>曾接受含 (peg)interferon 及 ribavirin 及合併或不合併 sofosbuvir 治療組合之患者  <ol>
<li>基因型第 1 、 2 、 4 、 5 或 6 型：  <ol>
<li>無肝硬化者，給付 8 週  </li>
<li>具代償性肝硬化 (Child Pugh score A) 者，給付 12 週  </li>
</ol>
</li>
<li>基因型第 3 型，且無肝硬化或具代償性肝硬化 (Child Pugh score A) 者，給付16 週  </li>
</ol>
</li>
<li>曾接受含 NS5A 抑制劑或 NS3/4A 蛋白酶抑制劑治療之基因型第 1 型患者：  <ol>
<li>若曾接受 NS3/4A 蛋白酶抑制劑治療，但未曾接受 NS5A 抑制劑治療者，給付12 週  </li>
<li>若曾接受 NS5A 抑制劑治療，但未曾接受 NS3/4A 蛋白酶抑制劑治療者，給付16 週  </li>
</ol>
</li>
</ol>
</li>
</ul>
<h3 id="sofosbuvirvelpatasvir-epclusa"><a class="toclink" href="../../../../medicine/daa/#sofosbuvirvelpatasvir-epclusa">Sofosbuvir/velpatasvir (Epclusa)</a></h3>
<ul>
<li>1# QD，Child-Pugh B/C可使用，Ccr &lt; 30不建議使用  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>未曾接受或曾接受全口服直接抗病毒藥物 (direct acting anti viral, DAAs) 治療，未併有或併有代償性肝硬化 (Child Pugh score A) 者，給付 12 週  </li>
<li>未曾接受或曾接受 DAAs 治療，併有失代償性肝硬化 (Child Pugh score B 或 C) 者，需合併 ribavirin 治療，給付 12 週  </li>
</ol>
</li>
<li>限未曾申請給付其他同DAAs且不得併用其他 DAAs ，惟若符合下列情形之一者，可再治療一次（一個療程）  <ol>
<li>接受本項藥品或其他 DAAs 第一次治療時中斷療程，且中斷原因屬專業醫療評估必須停藥者  </li>
<li>接受本項藥品或其他 DAAs 第一次治療結束後第 12 週 ，血中偵測不到病毒，目前血中又再次偵測到病毒者  </li>
<li>接受未含 NS5A 抑制劑之 DAAs 第一次治療，於治療完成時或治療結束後第 12 週，血中仍偵測到病毒者，或治療 4 週後之病毒量未能下降超過二個對數值（即下降未達100 倍發生在108年1月1日前）  </li>
</ol>
</li>
</ul>
<h3 id="sofosbuvirvelpatasvirvoxilaprevir-vosevi"><a class="toclink" href="../../../../medicine/daa/#sofosbuvirvelpatasvirvoxilaprevir-vosevi">Sofosbuvir/velpatasvir/voxilaprevir (Vosevi)</a></h3>
<ul>
<li>限使用於HCV RNA為陽性，且未併有肝硬化或併有代償性肝硬化（ Child Pugh A 級）之病毒基因型第 1 型、第 2 型、第 3 型、第 4 型、第 5 型或第 6 型病患  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>基因型 1 、 2 、 3 、 4 、 5 、 6 ，且曾接受含 NS5A 抑制劑治療失敗者，給付 12 週  </li>
<li>基因型 1a 或 3 ，且曾經接受含 sofosbuvir 但無 NS5A 抑制劑治療失敗者，給付 12週  </li>
</ol>
</li>
<li>限未曾申請給付本藥品且曾接受其他全口服直接抗病毒藥物（ direct acting anti viral, DAAs ）第一次治療並符合下列情形之一者  <ol>
<li>接受第一次治療時中斷療程，且中斷原因屬專業醫療評估必須停藥者。  </li>
<li>接受第一次治療完成時或治療結束後第 12 週，血中仍偵測到病毒者，或治療 4 週後之病毒量未能下降超過二個對數值（即下降未達 100 倍）發生在 108 年 1 月 1日前者  </li>
</ol>
</li>
</ul>
<h2 id="recommendations-for-retreatment-of-hepatitis-c-virusinfected-adults-by-prior-exposure"><a class="toclink" href="../../../../medicine/daa/#recommendations-for-retreatment-of-hepatitis-c-virusinfected-adults-by-prior-exposure">Recommendations for Retreatment of Hepatitis C Virus–Infected Adults by Prior Exposure</a></h2>
<table>
<thead>
<tr>
<th>Regimen</th>
<th>Genotype</th>
<th>Classification</th>
<th>Duration</th>
<th>Rating</th>
<th>Caveats and Other Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sofosbuvir-based treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir</td>
<td>1–6</td>
<td>Recommended</td>
<td>12 wk</td>
<td>I, A</td>
<td>For genotype 3 infection with compensated cirrhosis, add weight-based ribavirin if there are no contraindications.</td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir</td>
<td>1, 2, 4, 5, 6</td>
<td>Alternative</td>
<td>16 wk</td>
<td>I, A</td>
<td>Not recommended for patients with prior exposure to an NS5A inhibitor plus NS3/4A protease inhibitor regimen (eg, elbasvir/grazoprevir).</td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir + sofosbuvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>16 wk</td>
<td>IIa, B</td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir</td>
<td>1–6</td>
<td>Recommended</td>
<td>12 wk</td>
<td>IIa, B</td>
<td>For patients with compensated cirrhosis, addition of weight-based ribavirin is recommended (rating IIa, C).</td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir or sofosbuvir + glecaprevir/pibrentasvir treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir + sofosbuvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>16 wk</td>
<td>IIa, B</td>
<td>Extension to 24 wk should be considered in extremely difficult cases (eg, genotype 3 infection with compensated cirrhosis) or failure following sofosbuvir + glecaprevir/pibrentasvir therapy.</td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>IIa, B</td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir- or NS5A inhibitor–based treatment failure with decompensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>II, Ca</td>
<td>Low initial dose of ribavirin (600 mg) is recommended for patients with CTP class C cirrhosis; increase as tolerated.</td>
</tr>
<tr>
<td>Ledipasvir/sofosbuvir + weight-based ribavirin</td>
<td>1, 4, 5, 6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>II, Cb</td>
<td>Low initial dose of ribavirin (600 mg) is recommended for patients with CTP class C cirrhosis; increase as tolerated.</td>
</tr>
</tbody>
</table>
<p>Abbreviations: CTP, Child–Turcotte–Pugh score; NS3/4A, hepatitis C virus nonstructural protein 3–4A; NS5A, hepatitis C virus nonstructural protein 5A.<br />
<sup>a</sup> Only available data for genotypes 5 or 6 infection are in a small number of persons with compensated cirrhosis.<br />
<sup>b</sup> Only available data for genotype 6 infection are in persons with compensated cirrhosis.</p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-04-04 00:00:00">April 4, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../../../category/medicine/" class="md-meta__link">medicine</a></li>
        
        
          
          <li class="md-meta__item">
            
              1 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="b"><a class="toclink" href="../../../../medicine/hbv/">B肝藥物給付條件</a></h2>
<p>Lamivudine 100mg, entecavir, telbivudine, tenofovir disoproxil, tenofovir alafenamide用於慢性病毒性 B 型肝炎患者之條件如下：  </p>
<ol>
<li>
<p>HBsAg(+)且已發生肝代償不全者  </p>
</li>
<li>
<p>慢性Ｂ型肝炎病毒帶原者HBsAg(+)，或HBsAg(-)但B型肝炎核心抗體(anti-HBc)陽性者，接受非肝臟之器官移植者、接受癌症化學療法中、接受肝臟移植者、異體造血幹細胞移植、接受免疫抑制劑治療者、確診為肝癌並接受根除性治療且可檢驗到血清HBV DNA、肝硬化病患符合HBsAg(+)且可檢驗到血清HBV DNA＋有切片、超音波（肝硬化併食道或胃靜脈曲張、超音波診斷為肝硬化併脾腫大、超音波診斷為肝硬化且血小板&lt;120,000/μL，或肝硬度超音波診斷為肝硬化）、CT或MRI診斷為肝硬化診斷  </p>
</li>
<li>
<p>HBsAg(+)超過6個月（或IgM anti-HBc為陰性）及HBeAg(+)，且符合以下條件之一者，其給付療程為治療至e抗原轉陰並再給付最多12個月  </p>
<ol>
<li>
<p>ALT 值大於(或等於)正常值上限5倍以上(ALT≧5X)  </p>
</li>
<li>
<p>ALT 值介於正常值上限2至5倍之間(2X≦ALT&lt;5X)，且血清 HBVDNA≧20,000 IU/mL，或經由肝組織切片（血友病患及類血友病患經照會消化系專科醫師同意後，得不作切片）證實 HBcAg 陽性  </p>
</li>
<li>
<p>經由肝組織切片或肝臟纖維化掃描或 Fibrosis-4 (FIB-4)證實，等同 METAVIR system 纖維化大於或等於 F3者，其 ALT 值半年有兩次以上（間隔大於3個月）大於正常值上限(ALT&gt;X)，且血清HBV DNA≧ 20,000 IU/mL 或經由肝組織切片（血友病患及類血友病患經照會消化系專科醫師同意後，得不作切片）證實 HBcAg 陽性之患者  </p>
</li>
</ol>
</li>
<li>
<p>HBsAg(+)超過6個月（或IgM anti-HBc為陰性）及HBeAg(-)，且符合以下條件之一者，其療程至少二年，治療期間需檢驗血清 HBV DNA，並於檢驗血清 HBV DNA 連續三次，每次間隔 6 個月，均檢驗不出 HBV DNA 時停藥，每次療程至多給付 36 個月  </p>
<ol>
<li>
<p>ALT值大於或等於正常值上限 2 倍以上(ALT≧ 2X)，且血清 HBV DNA≧2,000 IU/mL，或經由肝組織切片（血友病患及類血友病患經照會消化系專科醫師同意後，得不作切片）證實 HBcAg 陽性。惟Fofnir、Hepwin、Sebivo、Ricovir、Hepuri、Virclean、Teno B、Tenof、Viread、Livepro、Lamidine、Hepar-Pro、Hepato-Ease、Barazer、Becavir等除上述條件外，應符合ALT值半年有兩次以上(每次間隔 3 個月)大於或等於正常值上限 2 倍以上(ALT≧ 2X)  </p>
</li>
<li>
<p>肝纖維化程度大於或等於 F2，其 ALT 值半年有兩次以上（間隔大於 3 個月）大於正常值上限(ALT&gt;X)，且血清HBV DNA≧ 20,000 IU/mL或經由肝組織切片（血友病患及類血友病患經照會消化系專科醫師同意後，得不作切片）證實 HBcAg陽性。惟Fofnir、Hepwin、Sebivo、Ricovir、Hepuri、Virclean、Teno B、Tenof、Viread、Livepro、Lamidine、Hepar-Pro、Hepato-Ease、Barazer、Becavir等除上述條件外，應符合肝纖維化程度大於或等於F3  </p>
</li>
</ol>
</li>
</ol>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-03-11 00:00:00">March 11, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../../../category/medicine/" class="md-meta__link">medicine</a></li>
        
        
          
          <li class="md-meta__item">
            
              1 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="dyslipidemia"><a class="toclink" href="../../../../medicine/dyslipidemia/">Dyslipidemia何時要治療</a></h2>
<p><img alt="Dyslipidemia.png" src="../../assets/images/Dyslipidemia.png" /><br />
* 心血管疾病定義：<br />
    * 冠狀動脈粥狀硬化患者包含：心絞痛病人，有心導管證實或缺氧性心電圖變化或負荷性試驗陽性反應者(附檢查報告)<br />
    * 缺血型腦血管疾病病人包含：<br />
        * 腦梗塞。<br />
        * 暫時性腦缺血患者(TIA)。（診斷須由神經科醫師確立）<br />
        * 有症狀之頸動脈狹窄。（診斷須由神經科醫師確立）<br />
* 危險因子定義：<br />
    1. 高血壓<br />
    2. 男性≧45歲，女性≧55歲或停經者<br />
    3. 有早發性冠心病家族史(男性≦55歲，女性≦65歲)<br />
    4. HDL-C&lt;40mg/dL<br />
    5. 吸菸（因吸菸而符合起步治療準則之個案，若未戒菸而要求藥物治療，應以自費治療）  </p>
<p><img alt="Dyslipidemia-1.png" src="../../assets/images/Dyslipidemia-1.png" />  </p>
<p><img alt="Dyslipidemia-2.png" src="../../assets/images/Dyslipidemia-2.png" /><br />
<img alt="statin-1.jpg" src="../../assets/images/statin-1.jpg" /><br />
<img alt="statin-2.png" src="../../assets/images/statin-2.png" /></p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-02-08 00:00:00">February 8, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../../../category/medicine/" class="md-meta__link">medicine</a>, 
              <a href="../../../../category/hiv/" class="md-meta__link">hiv</a></li>
        
        
          
          <li class="md-meta__item">
            
              1 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="pre-exposure-prevention"><a class="toclink" href="../../../../medicine/prep/">Pre-exposure Prevention</a></h2>
<p><img alt="PrEP-3.png" src="../../assets/images/PrEP-3.png" />  </p>
<h3 id="on-demand-prep"><a class="toclink" href="../../../../medicine/prep/#on-demand-prep">On-Demand PrEP</a></h3>
<h4 id="_1"><a class="toclink" href="../../../../medicine/prep/#_1">單次性行為</a></h4>
<ul>
<li>使用者於擬發生不安全性行為前2至24小時服用<strong>2顆</strong>，服藥後<strong>24小時</strong>、<strong>48小時</strong>，各服用1顆。  </li>
<li>假設不安全性行為發生點是星期五晚上10點，使用者服用方式為星期五晚上6點服用2顆（事前2-24小時服用2顆），星期六、日晚上6點再各服用1顆（服藥後24小時、48小時各1顆）<br />
<img alt="PrEP-2.png" src="../../assets/images/PrEP-2.png" />  </li>
</ul>
<h4 id="_2"><a class="toclink" href="../../../../medicine/prep/#_2">連續性行為</a></h4>
<ul>
<li>使用者在可能發生不安全性行為的前2至24小時服用<strong>2顆</strong>，於服藥後每隔24小時再服藥<strong>1顆</strong>，直到最後一次性行為之後<strong>2日</strong>為止。第2日起的服藥時刻是依據<strong>首次服藥日</strong>的時刻而定（也就是性行為前那一次服藥的時刻），而非性行為發生的時刻。  </li>
<li>假設不安全性行為發生點是周末（星期五、六、日）且最後一次性行為在星期日，使用者服用方式為星期五晚上6點服用2顆（事前2-24小時服用2顆），星期六、日晚上6點各服用1顆（持續服藥）、星期一、二晚上6點各服用1顆。   </li>
</ul>
<p><img alt="PrEP-1.png" src="../../assets/images/PrEP-1.png" />  </p>
<h4 id="7"><a class="toclink" href="../../../../medicine/prep/#7">最後一次服藥到當次性行為時間間隔小於7天</a></h4>
<ul>
<li>若使用者在最後一次服藥距離當次性行為時間間隔小於7天，當次性行為前2至24小時僅須服用<strong>1顆</strong>，並在服藥後的24小時、48小時服藥，完成此次依需求使用暴露前預防性投藥。  </li>
<li>假設不安全性行為發生點是星期一及星期六晚上（最後一次服藥到當次性行為時間間隔小於7天），使用者服用方式為星期一晚上6點服用<strong>2顆</strong>（事前2-24小時服用2顆），星期二、三晚上6點再各服用1顆（服藥後24小時、48小時各1顆），星期六晚上6點服用1顆（最後一次服藥到當次性行為時間間隔小於7天，事前2-24小時僅須服用1顆），星期日、一晚上6點再各服用1顆（服藥後24小時、48小時各1顆）。<br />
<img alt="PrEP.png" src="../../assets/images/PrEP.png" /></li>
</ul>
    
  </div>
</article>
      
      
        
          



<nav class="md-pagination">
  <a class="md-pagination__link" href="../../">1</a> <a class="md-pagination__link" href="../2/">2</a> <span class="md-pagination__current">3</span>
</nav>
        
      
    </div>
  </div>

          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
    
      
      <nav class="md-footer__inner md-grid" aria-label="Footer" >
        
          
          <a href="../../../../category/writing/" class="md-footer__link md-footer__link--prev" aria-label="Previous: writing">
            <div class="md-footer__button md-icon">
              
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
            </div>
            <div class="md-footer__title">
              <span class="md-footer__direction">
                Previous
              </span>
              <div class="md-ellipsis">
                writing
              </div>
            </div>
          </a>
        
        
          
          <a href="../../../2023/" class="md-footer__link md-footer__link--next" aria-label="Next: 2023">
            <div class="md-footer__title">
              <span class="md-footer__direction">
                Next
              </span>
              <div class="md-ellipsis">
                2023
              </div>
            </div>
            <div class="md-footer__button md-icon">
              
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M4 11v2h12l-5.5 5.5 1.42 1.42L19.84 12l-7.92-7.92L10.5 5.5 16 11H4Z"/></svg>
            </div>
          </a>
        
      </nav>
    
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../../../..", "features": ["navigation.path", "navigation.footer"], "search": "../../../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../../../assets/javascripts/bundle.af256bd8.min.js"></script>
      
        <script src="../../../../js/timeago.min.js"></script>
      
        <script src="../../../../js/timeago_mkdocs_material.js"></script>
      
        <script src="../../../../javascripts/mathjax.js"></script>
      
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
      
        <script src="https://cdn.jsdelivr.net/gh/ObsidianPublisher/assets@main/dist/javascript.js"></script>
      
    
  </body>
</html>